A story about de novo lipogenesis -more than just a shunting yard for glucose TJ 1.

Slides:



Advertisements
Similar presentations
Adipose Tissue - Fed State
Advertisements

ADIPONECTIN Its emerging role in Atherosclerosis, Metabolic Syndrome and Insulin Resistance RT ERASMUS Chemical Pathology, Tygerberg Hospital, NHLS &University.
LIPOPROTEIN METABOLISM
Acetyl-CoA Carboxylase-A New Target in the Fight against Obesity Naida Idrizovic.
Introduction  lipids are a good source of energy as 1 gm supplies 9.1 calories, which is over double that supplied by carbohydrates or protein.  Dietary.
Propionate metabolism
Regulation of Metabolic Pathways Systems must respond to conditions Homeostasis is not equilibrium Dynamic Steady State –Flux - Rate of metabolic flow.
Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery & Therapeutics Stimulation of Adipogenesis Altogen Labs.
Hormonal regulation of carbohydrate metabolism
cardio protection: Focus on
Metabolic effects of Insulin and Glucagon Metabolism in the Well fed state Metabolism in the Starvation and Diabetes Mellitus Integration of Metabolism.
Post-Absorptive Lipid Metabolism
Glycolysis Regualtion
Chapter 28, Stryer Short Course
Cholesterol Metabolism.  The chemical and biochemical aspects of cholesterol regarding structure, distribution and biological functions in human body.
Fatty Acid Metabolism 1. Fatty acid synthesis.
Hormonal regulation of lipid metabolism
Various roles SIK3 SIK1 SIK2 Energy metabolism Condrogenesis
Hormonal regulation of lipid metabolism
CHOLESTEROL BIOSYNTHESIS
The Endocrine Pancreas
Fatty acid synthesis (Lipogenesis & Lipolysis)
METABOLISM OF LIPIDS: SYNTHESIS OF FATTY ACIDS
MYC, Metabolism and Cancer
LIPIDS AND LIPOPROTEINS Dr. Gamal Gabr
Cholesterol Synthesis, Transport, & Excretion
Figure 6 Cholesterol metabolism in obesity-related glomerulopathy
GLYCOLYSIS EMVB | HLY.
LIPID METABOLISM.
Figure 21.1 Humans can use a variable fuel input to meet a variable metabolic demand. Textbook of Biochemistry with Clinical Correlations, 7e edited by.
Figure 1 Pathophysiological aspects of insulin
Figure 5 Sterol regulatory element-binding
Volume 47, Issue 1, Pages (July 2007)
AMPK is activated by HCMV; inhibition of the kinase blocks the glycolytic activation that is normally induced by infection and markedly reduces the production.
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Candidate signalling pathways of irisin in hepatocytes
Figure 1 A schematic representation of the HER2 signalling pathway
Figure 1 Overview of lipoprotein metabolism and effects of novel lipid-modulating approaches Figure 1 | Overview of lipoprotein metabolism and effects.
Figure 2 Intracellular actions of metformin
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Control of hepatic gluconeogenesis
Advanced Nutrition Lipids 5 MargiAnne Isaia, MD MPH.
Figure 2 Control of hepatic glycogen metabolism
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 mTOR complex biology
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Lipoproteins.
Cristoforo Silvestri, Vincenzo Di Marzo  Cell Metabolism 
An Emerging Role of mTOR in Lipid Biosynthesis
Sweet Sixteenth for ChREBP: Established Roles and Future Goals
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Konstantinos G. Michalakis, M.D., James H. Segars, M.D. 
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Volume 19, Issue 2, Pages (February 2014)
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis  Kosaku Uyeda,
Knockdown of MPST weakens JNK phosphorylation, ameliorates hepatic oxidative stress and suppresses the release of MCP-1. Knockdown of MPST weakens JNK.
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis  Kosaku Uyeda,
Protein Tyrosine Phosphatase 1B
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Lipoproteins   Macromolecular complexes in the blood that transport lipids Apolipoproteins   Proteins on the surface of lipoproteins; they play critical.
The Salt-Inducible Kinases: Emerging Metabolic Regulators
Volume 104, Issue 4, Pages (February 2001)
Glucagon – A hormone from pancreas Lecture NO: 2nd MBBS
The Endocrine Pancreas
Figure 1 Thyroid hormone effects on hepatic lipid metabolism
Connections between insulin/insulin-like growth factor 1 signaling and metabolic pathways in tumor cells. Connections between insulin/insulin-like growth.
Main metabolic pathways deregulated in cancers and corresponding targeting drugs. Main metabolic pathways deregulated in cancers and corresponding targeting.
Presentation transcript:

A story about de novo lipogenesis -more than just a shunting yard for glucose TJ 1

Sampled data at routine work ACC1 enzymic assay ACC2 enzymic assay C14-acetate incorporation assay

Why more and more Fasyn project coming? What is ACC? How it works? What did we do in the past? Where is Acetate-CoA from? Where to go? Any other targets? How does fatty acid synthesis (FAsyn) induce diseases? What is ACL? What two protocol used for, Chloroform/methanol VS. Saponification? The relationship between FAsyn and cancer? ?????…

Inhibition of ACC1 and ACC2 activity Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 Abuelheiga,L., et al., Science, 2001.  Tong, L. and H.J. Harwood, Jr., J Cell Biochem, 2006. Harwood, H. J., Jr., et al. (2003) J Biol Chem

Distinct roles of ACC1 and ACC2 in FA metabolism  Tong, L. and H.J. Harwood, Jr., J Cell Biochem, 2006.

Structures of biotin carboxylase (BC) domain of ACC Harriman, G., et al. (2016). PNAS Tong, L. (2005). Cell Mol Life Sci Svensson, R. U., et al. (2016). Nat Med.

ACC activity and FAsyn regulation Wang, C., et al. (2015). "Expert Rev Anticancer Ther SREBP-1c: regulatory element-binding protein-1c ChREBP: carbohydrate response element-binding protein AMPK: AMP-activated protein kinase LXRs: liver X receptors There are three SREBP family members, designated SREBP-1a, -1c, and -2. The SREBP-1 isoforms predominantly regulate genes involved in FA and TG synthesis while the SREBP-2 isoform activates genes involved in cholesterol biosynthesis and cellular homeostasis Loubiere, C., et al. (2015). Oncotarget ACC activity regulation Phosphorylation/dephosphorylation by AMPK Transcriptional, mediated by SREBP-1c, ChREBP and liver X receptors (LXRs) Allosteric activation by high concentrations of citrate induced polymerization Kim, C. W., et al. (2010). PNAS

ACC inhibitors ND-630 ACC2 selective neurological and cardiovascular safety events ACC1/2 unselective increased lipid oxidation, can’t decrease TG and weight Harriman, G., et al. (2016). PNAS Griffith, D.A., et al., J Med Chem,2014 Svensson, R. U., et al. (2016). Nat Med.

Acetyl-CoA related pathways

More…?

From the very beginning Lipids Glucose The majority of adult mammalian tissues satisfy their lipid requirements through the uptake of free fatty acids (FFAs) and lipoproteins, such as low-density lipoprotein (LDL), from the bloodstream. Fatty acid (FA) and cholesterol biosynthesis are restricted to a subset of tissues, including liver, adipose and lactating breast tissues.

Lipid biosynthesis Baenke, F., et al. (2013). Dis Model Mech Detailed reaction refers to: Sanders, F. W. and J. L. Griffin (2016) Biol Rev Camb Philos Soc

Wnt/LRP6 regulation of LDL uptake and DNL Song, K., et al. (2014) Oncotarget LRP6 forms a complex with LDLR and other proteins of endocytic machinery involved in LDL LRP6 inhibits IGF1-IGF1R dependent activation of AKT/SREBP, DNL and PPARγ-dependent adipogenesis

Fat cell Most normal cells use dietary and/or exogenous lipids for synthesis of new structural lipids . Active FAsyn pathway in adipocytes, hepatocytes, hormone-sensitive cells and fetal lung tissue. In general, de novo fatty acid synthesis is suppressed in most normal cells. Sanders, F. W. and J. L. Griffin (2016). Biol Rev Camb Philos Soc

Fatty acid and cancer Cancer tissues can generate lipids Tumor takes up lipids from tissue environment Medes, G., et al. (1953). Cancer Res Tumor specific antigen OA-519 is FASN Kuhajda, F. P., et al. (1994). PNAS FAsyn inhibitors in different preclinical models Kuhajda, F. P., et al. (2000). PNAS FAsyn inhibition can block cancer growth Abramson, H. N. (2011). J Med Chem Zaidi, N., et al. (2012). Cancer Res THEN, ACC, SCD, ACLY…

Lipogenesis  Mounier,C., et al., Int J Oncol, 2014. 45(2): p. 485-92.

DNL in the control of metabolic homeostasis Solinas, G., et al. (2015). Mol Metab Sanders, F. W. and J. L. Griffin (2016). Biol Rev Camb Philos Soc DNL produces lipids by disposing of glucose and calories. DNL supports the synthesis of several signaling molecules implicated in the control of metabolic homeostasis.

The roles of lipids in the tumor microenvironment Hypoxia means low oxygen HIF, hypoxia inducible factor, a transcription factor mediates cellular response to hypoxia Baenke, F., et al. (2013). Dis Model Mech

Lead optimization to ND-630

Acute in vivo efficacy of ND-630 in rats Chow-fed male Sprague-Dawly rats HSD-induced obesity ZDF rats

Lead optimization to ND-646

Final answer for ACC phosphorylation inhibition Svensson, R. U., et al. (2016). Nat Med. calyculin A (Cal A), protein phosphatase inhibitor To test how ND-646 inhibit p-ACC: Did not prevent the ability of AMPK to phosphorylate hACC2 at Ser222 No effect on other AMPK substrates Might promote dephosphorylation of p-Ser hACC1 R172A mutation, p-Ser was gone; +Cal A, p-Ser restored SO WHAT???

Fat isn’t just something we eat: it may also lie at the heart of a new approach to treating cancer.